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Severe chronic thromboembolic pulmonary hypertension  
in a patient after splenectomy for hereditary spherocytosis: 
the need for long-term surveillance and closer cooperation 
between haematologists and cardiologists
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Abstract
We present the case of a 34-year-old female patient with severe pulmonary hypertension diagnosed > 15 years after 
splenectomy to emphasize the need to monitor patients after splenectomy for the development of chronic thrombo-
embolic pulmonary hypertension (CTEPH). The lack of screening tests for this group of patients, as in the described 
case, resulted in a serious clinical condition of the patient at the time of diagnosis. Without specialized treatment, the 
probability of her survival at 5 years was only 10%. Close collaboration between haematologists and cardiologists is 
mandatory in the management of post-splenectomy patients Life-long surveillance is needed in these patients due to 
the risk of CTEPH. The development of a screening program for post-splenectomy patients is required.
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Introduction
We present a case of a young patient with severe pulmonary 
hypertension (PH) diagnosed > 15 years after splenectomy 
to emphasize the need for monitoring of patients after sple-
nectomy for the development of chronic thromboembolic 
pulmonary hypertension (CTEPH).
Case report
A 34-year-old woman was admitted to the hospital due to 
suspected PH. In childhood, she underwent splenectomy 
due to congenital spherocytosis at the age of 16 (2002). 
In December 2018, there was a pulmonary embolism (PE) 
treated with thrombolysis, and a month later she underwent 
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Figure 1A. Echocardiography shows the enlargement of the right heart chambers and pulmonary trunk: right ventricle (RVID) 53 mm, right 
atrial area 28 cm2, RV:LV ratio 1.4. D-shaped left ventricle in systole, secondary to interventricular septum flattening, indicates the right 
ventricular pressure overload. Severe tricuspid regurgitation is shown with the peak velocity of 4.8 m/s; B. Lung scintigraphy shows nume-
rous segmental and subsegmental perfusion deficits in both lungs (white arrows); C. Pulmonary angiography reveals the widening of main 
branches of the pulmonary artery, organized clots located in the distal parts of both lower lobes branches (red asterisks) and multiple webs 
lesions at segmental levels. From the left: right pulmonary artery (posteroanterior and right anterior-posterior oblique 90 views) and left 
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urgent pulmonary endarterectomy (PEA) and removal of the 
inferior vena cava filter.
Discussion
Splenectomy is considered a risk factor for CTEPH develop-
ment and a history of splenectomy is found in 3.4–9.1% of 
CTEPH patients [1, 2]. CTEPH may occur many years after 
splenectomy [3]. The diagnosis of CTEPH may be chal-
lenging, but this does not fully explain the late diagnosis 
in the presented case. This could be due to low awareness 
of the risk of CTEPH after splenectomy and the lack of 
recommendations for monitoring these patients. CTEPH 
is a rare disease that, if untreated, leads to RV failure and 
death. In the case of untreated CTEPH and mPAP exceed-
ing 50 mm Hg (57 mm Hg in the presented patient), 5-year 
survival was only 10% [4]. However, successful treatment 
with PEA reduces the risk of death by 67% compared to non-
operated patients [5]. In patients not eligible for surgery, 
percutaneous balloon pulmonary angioplasty is an option. 
Also targeted pharmacotherapy for PH is administered, 
mainly using riociguat.
Conclusion
Close collaboration between haematologists and cardiolo-
gists is mandatory in the management of post-splenectomy 
patients. They require life-long surveillance due to the risk 
of CTEPH. The development of a screening program for 
post-splenectomy patients is required.
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surgical recanalization of deep veins in the right lower limb 
and filter implantation into the inferior vena cava. Three 
months later, deep vein thrombosis was diagnosed, while 
taking enoxaparin. Despite anticoagulation, PE recurred in 
August 2019 and left iliac vein thrombosis was diagnosed. 
Thrombophilia was excluded.
On admission, the patient complained of progressive 
dyspnoea [New York Heart Association (NYHA) III] and re-
current syncopes.
In laboratory tests: haemoglobin 17 g/dL, haema-
tocrit 53%, platelets 560 × 109/L and BNP 169 pg/mL. 
Electrocardiography (ECG) showed sinus tachycardia, 
right axis deviation, P-pulmonale, right ventricular (RV) 
hypertrophy.
Echocardiography revealed (see Supplementary vid-
eos):
 — normal left ventricular (LV) systolic function: LV ejec-
tion fraction 60%;
 — right heart and pulmonary trunk enlargement;
 — impaired RV systolic function: three–dimensional RV 
ejection fraction 31%, RV free wall longitudinal strain 
–10%, RV S’ 10 cm/s;
 — severe tricuspid regurgitation, and RV systolic pressure 
of 100 mmHg (Figure 1A).
Angio-CT showed no evidence of acute PE. Perfu-
sion scintigraphy revealed numerous perfusion deficits 
in both lungs at the segmental and subsegmental levels 
(Figure 1B). Right heart catheterization indicated preca-
pillary PH: mean pulmonary artery pressure (mPAP) was 
57 mm Hg, pulmonary vascular resistance 8.93 Wood units, 
pulmonary capillary wedge pressure 12 mm Hg, and the 
cardiac index was 2.56 L/min/m2. Pulmonary artery angio-
graphy showed numerous contrast deficits (Figure 1C), and 
finally, CTEPH was diagnosed. The patient was qualified for 
Streszczenie
Przedstawiono przypadek 34-letniej pacjentki z ciężkim nadciśnieniem płucnym (PH) zdiagnozowanym ponad 15 lat 
po splenektomii, aby podkreślić potrzebę monitorowania pacjentów po tym zabiegu pod kątem rozwoju przewlekłego 
zakrzepowo-zatorowego nadciśnienia płucnego (CTEPH). Jak dotąd, brakuje zaleceń odnośnie do badań przesiewowych 
u chorych po splenektomii, co w opisanym przypadku skutkowało ciężkim PH u chorej w momencie podstawienia diag-
nozy. Bez podjęcia specjalistycznego leczenia prawdopodobieństwo jej 5-letniego przeżycia wynosiło zaledwie 10%. 
Pacjenci po splenektomii wymagają ścisłej współpracy między hematologami i kardiologami oraz stałej obserwacji przez 
całe życie ze względu na ryzyko wystąpienia CTEPH. Konieczne jest opracowanie programu badań przesiewowych dla 
pacjentów po splenektomii.
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